EP 1740175 A1 20070110 - USE OF A CGRP-ANTAGONIST COMBINED WITH A SEROTONIN-REUPTAKE INHIBITOR IN ORDER TO TREAT MIGRAINES
Title (en)
USE OF A CGRP-ANTAGONIST COMBINED WITH A SEROTONIN-REUPTAKE INHIBITOR IN ORDER TO TREAT MIGRAINES
Title (de)
VERWENDUNG EINES CGRP-ANTAGONISTEN IN KOMBINATION MIT EINEM SEROTONIN-WIEDERAUFNAHME-HEMMER ZUR BEHANDLUNG VON MIGRÄNE
Title (fr)
UTILISATION D'UN ANTAGONISTE DE CGRP EN COMBINAISON AVEC UN INHIBITEUR DE RECAPTAGE DE LA SEROTONINE POUR LE TRAITEMENT DES MIGRAINES
Publication
Application
Priority
- EP 2005004076 W 20050418
- DE 102004019736 A 20040420
- DE 102004063754 A 20041229
Abstract (en)
[origin: WO2005102322A1] The invention relates to a method for treating or preventing headaches, migraines or cluster headaches. Said method involves the common administration of a therapeutically active amount of a CGRP-antagonist (A) or a physiologically compatible salt thereof, and a therapeutically active amount of a serotonin-reuptake inhibitor (B) or a physiologically compatible salt thereof. The invention also relates to the corresponding pharmaceutical compositions and to the production thereof.
IPC 8 full level
A61K 31/4178 (2006.01); A61K 31/4196 (2006.01); A61K 31/513 (2006.01); A61K 31/551 (2006.01); A61K 38/05 (2006.01); A61P 25/06 (2006.01)
CPC (source: EP)
A61K 31/4178 (2013.01); A61K 31/4196 (2013.01); A61K 31/513 (2013.01); A61K 31/551 (2013.01); A61P 25/04 (2017.12); A61P 25/06 (2017.12); A61P 43/00 (2017.12)
Citation (search report)
See references of WO 2005102322A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR
Designated extension state (EPC)
BA HR YU
DOCDB simple family (publication)
WO 2005102322 A1 20051103; CA 2563687 A1 20051103; EP 1740175 A1 20070110; JP 2007533685 A 20071122
DOCDB simple family (application)
EP 2005004076 W 20050418; CA 2563687 A 20050418; EP 05735425 A 20050418; JP 2007508808 A 20050418